LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Accueil・Liste d'Actions・Becton Dickinson and Co

Becton Dickinson and Co

Fermé

SecteurSoins de santé

147.7 0.8

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

147

Max

147.72

Chiffres clés
By Trading Economics
Revenu	-692M -310M
Ventes	-538M 4.7B
P/E Moyenne du Secteur	24.8 49.701
BPA	2.9
Rendement du dividende	2.91
Marge bénéficiaire	-6.576
Employés	60,000
EBITDA	-1B 189M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+23.42% upside

Dividendes
By Dow Jones
Rendement du dividende Moyenne du Secteur	2.91% 2.39%
Prochains Résultats	6 août 2026
Date du Prochain Dividende	30 juin 2026
Date du Prochain Détachement de Dividende	9 juin 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-2.4B 39B
Ouverture précédente	146.9
Clôture précédente	147.7

Sentiment de l'Actualité

By Acuity

24%

76%

43 / 345 Classement par Healthcare

Becton Dickinson and Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2025, 11:19 UTC

Résultats

Becton Dickinson Boosts Outlook as 3Q Results Beat Estimates

14 juil. 2025, 14:26 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 juil. 2025, 11:08 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

14 juil. 2025, 10:37 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal

7 août 2025, 10:32 UTC

Résultats

Becton Dickinson Expects to Complete Remaining $250M of $1B Share-Buyback Commitment by End FY25 >BDX

7 août 2025, 10:31 UTC

Résultats

Becton Dickinson Backs FY25 View of Rev $21.8B-$21.9B >BDX

7 août 2025, 10:31 UTC

Résultats

Becton Dickinson Had Seen FY25 Adjusted EPS $14.06-$14.34 >BDX

7 août 2025, 10:30 UTC

Résultats

Becton Dickinson Raises FY25 View To Adj EPS $14.30-Adj EPS $14.45 >BDX

7 août 2025, 10:30 UTC

Résultats

Becton Dickinson 3Q Adj EPS $3.68 >BDX

7 août 2025, 10:30 UTC

Résultats

Becton Dickinson 3Q Net $574M >BDX

7 août 2025, 10:30 UTC

Résultats

Becton Dickinson 3Q Rev $5.51B >BDX

7 août 2025, 10:30 UTC

Résultats

Becton Dickinson 3Q EPS $2.00 >BDX

15 juil. 2025, 18:32 UTC

Acquisitions, Fusions, Rachats

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 juil. 2025, 18:31 UTC

Acquisitions, Fusions, Rachats

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 juil. 2025, 16:12 UTC

Market Talk

Acquisitions, Fusions, Rachats

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 juil. 2025, 15:06 UTC

Acquisitions, Fusions, Rachats

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 juil. 2025, 14:11 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 juil. 2025, 10:53 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 juil. 2025, 10:21 UTC

Acquisitions, Fusions, Rachats

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 juil. 2025, 10:20 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 juil. 2025, 10:17 UTC

Acquisitions, Fusions, Rachats

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

Comparaison

Variation de prix

Becton Dickinson and Co prévision

Objectif de Prix

By TipRanks

23.42% hausse

Prévisions sur 12 Mois

Moyen 182.2 USD 23.42%

Haut 221 USD

Bas 159 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

10 ratings

Achat

Maintien

Vente

Basé sur 10 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

43 / 345Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.